Histology Important in Treatment of Non-Small Cell Lung Cancer With ALIMTA
emaxhealth.com     May 17, 2008            

Lung Cancer Symptoms and Treatment Lung cancer patients whose histology is factored into treatment decisions may fare better as a result, according to data from a pivotal non-small cell lung cancer (NSCLC) clinical trial. Data from the trial, which involved Eli Lilly and Company's ALIMTA... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

                   

Nexavar Works for Liver Cancer, But It Isn’t Cheap

wsj.com     8 hrs ago   14 related          

The study of Nexavar for liver cancer that was the talk of last year’s ASCO conference gets its closeup this week, with publication of the full results in the New England Journal of Medicine. The basic findings are the same as...                

comments

                   

Merck Serono Receives European Approval For Broader Usage Of Erbitux In Metastatic Colorectal...

medicalnewstoday.com     13 hrs ago   3 related          

Merck KGaA announced today that it has been granted approval by the European Commission for Erbitux® (cetuximab), to update its license for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing, KRAS...                

comments

                   

Seattle Genetics Inc. Q2 2008 Earnings Call Transcript

seekingalpha.com     yesterday   4 related          

posted on: July 22, 2008 | about stocks: SGEN Executives Peggy Pinkston - We reported final data from our Phase I SGN-40 clinical trial in non-Hodgkin lymphoma at the International Conference on Malignant Lymphoma in June,...                

comments

                   

Protherics Plc Interim Management Statement

redorbit.com     yesterday   6 related          

Protherics PLC AGM and Interim Management Statement London, UK; Brentwood, TN, US; 22 July 2008 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer,...                

comments